Log In
BCIQ
Print this Print this
 

MtbuVax

  Manage Alerts
Collapse Summary General Information
Company Vaxil Bio Ltd.
DescriptionSynthetic T cell subunit vaccine against the Mycobacterium based on VaxHit technology
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationTuberculosis
Indication DetailsPrevent tuberculosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/29/2016

Undisclosed

Undisclosed

Undisclosed

10/18/2010

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today